Chemcrux Enterprises Limited (CHEMCRUX.BO)
- Previous Close
147.25 - Open
149.50 - Bid 146.00 x --
- Ask 146.50 x --
- Day's Range
142.00 - 149.50 - 52 Week Range
100.20 - 184.70 - Volume
2,158 - Avg. Volume
11,510 - Market Cap (intraday)
2.167B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
38.70 - EPS (TTM)
3.78 - Earnings Date May 20, 2025
- Forward Dividend & Yield 1.00 (0.68%)
- Ex-Dividend Date Sep 6, 2024
- 1y Target Est
--
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, aceturic acid, lassamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride. It serves multinationals and pharmaceutical organizations. The company also exports its products. Chemcrux Enterprises Limited was founded in 1983 and is based in Vadodara, India.
www.chemcrux.com98
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CHEMCRUX.BO
View MorePerformance Overview: CHEMCRUX.BO
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEMCRUX.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEMCRUX.BO
View MoreValuation Measures
Market Cap
2.18B
Enterprise Value
2.23B
Trailing P/E
38.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.22
Price/Book (mrq)
2.96
Enterprise Value/Revenue
4.31
Enterprise Value/EBITDA
19.85
Financial Highlights
Profitability and Income Statement
Profit Margin
7.71%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
728.25M
Net Income Avi to Common (ttm)
56.13M
Diluted EPS (ttm)
3.78
Balance Sheet and Cash Flow
Total Cash (mrq)
240.16M
Total Debt/Equity (mrq)
38.93%
Levered Free Cash Flow (ttm)
--